Skip to main content
Log in

Intraperitoneal production of erythropoietin with continuous ambulatory peritoneal dialysis

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Higher hematocrit and serum erythropoietin (EPO) levels have previously been shown in end-stage renal disease patients treated with continuous ambulatory peritoneal dialysis (CAPD) compared with hemodialysis. We investigated whether EPO was produced intraperitoneally in CAPD patients. EPO concentration was 3.5±0.3 mU/ml by radioimmunoassay in 26 samples of peritoneal dialysis effluent obtained from 15 CAPD patients. EPO was not detectable in the fresh unused dialysate. No correlation was observed between EPO levels in the serum and dialysis effluent. Peritoneal macrophages were isolated from the dialysis effluent of 9 CAPD patients after an overnight dwell. The culture supernatant obtained after 24 h of in vitro culture of a million cells yielded EPO of 3.5±0.3 mU/ml. Our study demonstrated that peritoneal macrophages from CAPD patients produce EPO on in vitro stimulation, and EPO is present in the dialysis effluent of CAPD patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Chandra M, Clemons GK, McVicar M, Wilkes B, Bluestone PA, Mailloux LU, Mossey RT (1988) Serum erythropoietin levels and hematocrit in end-stage renal disease: influence of the mode of dialysis. Am J Kidney Dis 12: 208–213

    PubMed  Google Scholar 

  2. Zappacosta AR, Caro J, Erslev A (1982) Normalization of hematocrit in patients with end stage renal disease on continuous ambulatory peritoneal dialysis. Am J Med 72: 53–57

    PubMed  Google Scholar 

  3. Chandra M, McVicar M, Clemons G, Mossey RT, Wilkes BM (1987) Role of erythropoietin in the reversal of anemia of renal failure with continuous ambulatory peritoneal dialysis: a case report. Nephron 46: 312–315

    PubMed  Google Scholar 

  4. Rich IN, Kubanels B (1982) Release of erythropoietin from macrophages mediated by phagocytosis of crystalline silica. J Reticuloendothelial Soc 31: 17–30

    Google Scholar 

  5. Rich IN (1986) A role for the macrophage in normal haemopoiesis. II. Effect of varying physiological oxygen tensions on the release of haemopoietic growth factors from bone marrow derived macrophages in vitro. Exp Hematol 14: 746–751

    PubMed  Google Scholar 

  6. Garcia JF, Ebbe SN, Hollander L, Cutting HO, Miller ME, Cronkite EP (1982) Radioimmunoassay of erythropoietin: circulating levels in normal and polycythemic human beings. J Lab Clin Med 99: 624–635

    PubMed  Google Scholar 

  7. Wideroe TE, Sonengen T, Halvorsen S (1983) Erythropoietin and uremic toxicity during continuous ambulatory peritoneal dialysis Kidney Int 24 [Suppl 16]: 208–218

    Google Scholar 

  8. MacDougall IC, Roberts DE, Neubert P, Dharamasana AD, Coles GA, Williams JD (1989) Pharmacokinetics of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis. Lancet I: 425–427

    Google Scholar 

  9. Kromer G, Solf A, Ehmer B, Kaufman B, Quellhorst E (1990) Single dose pharmacokinetics of recombinant human erythropoietin comparing intravenous, subcutaneous and intraperitoneal administration in IPD patients. Kidney Int 37: 331A

    Google Scholar 

  10. Goldstein CS, Bomalaski JS, Zurier RB, Neilsen EG, Douglas SD (1984) Arlalysis of peritoneal macrophages in continuous ambulatory peritoneal dialysis. Kidney Int 26: 733

    PubMed  Google Scholar 

  11. Davies SJ, Suassuna J, Ogg CS, Cameron JS (1989) Activation of immunocompetent cell in the peritoneum of patients treated with CAPD. Kidney Int 36: 661–668

    PubMed  Google Scholar 

  12. Cichocki T, Hanicki Z, Sulowicz W, Smolenski O, Kopec J, Zembala M (1983) Output of peritoneal cells into peritoneal dialysate. Cytochemical and functional studies. Nephron 35: 175–182

    PubMed  Google Scholar 

  13. Topley N, Alobaidi Haifa MM, Davies M, Coles GA, Williams JD, Lloyd D (1988) The effect of dialysate on peritoneal phagocyte oxidative metabolism. Kidney Int 34: 404–411

    PubMed  Google Scholar 

  14. Boelaert JR, Schurgers ML, Matthys EG, Belpaire FM, Daneels RF, De Cre MJ, Bogaert MG (1989) Comparative pharmacokinetics of recombinant erythropoietin administered by the intravenous, subcutaneous and intraperitoneal routes in continuous ambulatory peritoneal dialysis patients (CAPD). Perit Dial Int 9: 95–98

    PubMed  Google Scholar 

  15. Flessner MF (1991) Peritoneal transport physiology: insights from basic research. J Am Soc Nephrol 2: 122–135

    PubMed  Google Scholar 

  16. Regoeczi E, Zaimi O, Chindemi PA, Charlwood PA (1989) Absorption of plasma proteins from peritoneal cavity of normal rats. Am J Physiol 256: E447-E452

    PubMed  Google Scholar 

  17. Bos HJ, Meyer F, De Veld JC, Beelen RHJ (1989) Peritoneal dialysis fluid induces change of mononuclear phagocyte proportions. Kidney Int 36: 20–26

    PubMed  Google Scholar 

  18. Dobbie JW (1990) New concepts in molecular biology and ultrastructural pathology of the peritoneum: their significance for peritoneal dialysis. Am J Kidney Dis 15: 97–109

    PubMed  Google Scholar 

  19. DiPaolo N, Sacchi G (1989) Peritoneal vascular changes in continuous ambulatory peritoneal dialysis (CAPD). An in vitro model for the study of diabetic microangiopathy. Perit Dial Int 9: 41–45

    PubMed  Google Scholar 

  20. Chandra M, McVicar M, Clemons G (1988) Evidence for intraperitoneal production of erythropoietin. Pediatr Res 23: 542A

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chandra, M., Clemons, G., Sahdev, I. et al. Intraperitoneal production of erythropoietin with continuous ambulatory peritoneal dialysis. Pediatr Nephrol 7, 281–283 (1993). https://doi.org/10.1007/BF00853222

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00853222

Key words

Navigation